Texas Biomed establishes new Tuberculosis Innovation and Technology Fund to improve research and treatments for world's deadliest infectious disease
SAN ANTONIO, April 22, 2026 /PRNewswire/ -- Texas Biomedical Research Institute has established a new $2 million Tuberculosis Innovation and Technology Fund supported by philanthropic investment to accelerate future TB discoveries, therapies and cures. Tuberculosis (TB) is the world's...
View original →